Zogenix competitors

Zippia score 4.4

Competitor Summary. See how Zogenix compares to its main competitors:

Pfizer has the most employees (78,500).

Work at Zogenix?

Share your experience

Zogenix vs competitors

Company	Founding date	Zippia score	Headquarters	# of Locations	Revenue	Employees
Zogenix	2006	4.4	Emeryville, CA	1	$81.7M	90
Neurelis	2007	4.2	Encinitas, CA	1	$3.0M	300
Aquestive Therapeutics	2004	4.2	Warren, NJ	2	$57.6M	100
Tonix Pharmaceuticals	2007	3.8	New York, NY	3	$12.7M	26
Saol Therapeutics	2015	3.9	Roswell, GA	1	$2.2M	66
Seelos Therapeutics	2016	3.6	New York, NY	1	$375,000	10
NeuroTherapeutics Pharma Inc	-		Chicago, IL	1	-	1
Axial Therapeutics	2016	3.7	Waltham, MA	2	$350,000	30
Omeros	1994	4.5	Seattle, WA	1	$29.9M	265
Endo Pharmaceuticals Inc	1997	4.7	Malvern, PA	3	$2.6B	385
Allergan plc	1948	4.8	Irvine, CA	1	$7.2B	11,400
Pfizer	1849	4.5	New York, NY	18	$63.6B	78,500
Salix Pharmaceuticals	1989	4.2	Raleigh, NC	2	$1.1B	1,000
Aqua Pharmaceuticals	2004	4.3	West Chester, PA	1	$8.6M	71
Quinnova Pharmaceuticals Including Sarms, Peptides and More	2003	3.4	Newtown, PA	1	$5.3M	75
BDI Pharma	1995	3.2	Columbia, SC	1	$620,000	50
Primus Pharmaceuticals	2000	3.9	Scottsdale, AZ	1	$17.5M	50
BDSI	1997	4.0	Raleigh, NC	1	$166.7M	200
Arbor Pharmaceuticals	2006	4.6	Atlanta, GA	1	$175.0M	157
Pernix Therapeutics Holdings	1996	3.8	Morristown, NJ	1	$146.1M	171
Horizon Pharma USA, Inc.	2005	4.6	Deerfield, IL	7	$25.0M	30

Rate Zogenix's competitiveness in the market.

Zogenix salaries vs competitors

Compare Zogenix salaries vs competitors

Company	Average salary	Hourly salary	Salary score
Zogenix	$71,837	$34.54	-

Compare Zogenix job title salaries vs competitors

Company	Highest salary	Hourly salary
Zogenix	$78,507	$37.74
Salix Pharmaceuticals	$100,449	$48.29
Allergan plc	$96,996	$46.63
Horizon Pharma USA, Inc.	$95,235	$45.79
Pfizer	$95,232	$45.78
Omeros	$78,340	$37.66
Endo Pharmaceuticals Inc	$75,892	$36.49
Aqua Pharmaceuticals	$73,824	$35.49
Saol Therapeutics	$73,479	$35.33
Pernix Therapeutics Holdings	$73,345	$35.26
Seelos Therapeutics	$73,238	$35.21
Arbor Pharmaceuticals	$73,142	$35.16
Quinnova Pharmaceuticals Including Sarms, Peptides and More	$72,503	$34.86
Primus Pharmaceuticals	$72,356	$34.79
Neurelis	$72,300	$34.76
Axial Therapeutics	$71,930	$34.58
BDI Pharma	$71,468	$34.36
BDSI	$71,395	$34.32
NeuroTherapeutics Pharma Inc	$70,640	$33.96
Aquestive Therapeutics	$70,516	$33.90

Do you work at Zogenix?

Is Zogenix able to compete effectively with similar companies?

Zogenix jobs

Zogenix demographics vs competitors

Compare gender at Zogenix vs competitors

Job title	Male	Female
Zogenix	51%	49%
BDSI	52%	48%
Endo Pharmaceuticals Inc	52%	48%
Pfizer	55%	45%
Horizon Pharma USA, Inc.	55%	45%
Arbor Pharmaceuticals	55%	45%

Male

Female

100%

75%

50%

25%

Arbor Pharmaceuticals

Horizon Pharma USA, Inc.

Pfizer

Endo Pharmaceuticals Inc

BDSI

Zogenix

25%

50%

75%

100%

Compare race at Zogenix vs competitors

Company	White	Hispanic or Latino	Black or African American	Asian	Unknown	Diversity score
Zogenix	60%	18%	9%	9%	4%	6.9
BDSI	63%	19%	11%	4%	3%	7.0
Pfizer	55%	18%	10%	13%	4%	9.8
Arbor Pharmaceuticals	65%	10%	16%	5%	4%	7.8
Endo Pharmaceuticals Inc	60%	13%	12%	11%	4%	9.8
Horizon Pharma USA, Inc.	61%	13%	12%	8%	5%	9.0

Zogenix and similar companies CEOs

CEOBio

Gregory A. Demopulos

Omeros

Gregory A. Demopulos, M.D. is one of our founders and has served as our President, Chief Executive Officer and Chairman of the Board of Directors since June 1994. Prior to founding Omeros, Dr. Demopulos completed his residency in orthopedic surgery at Stanford University and his fellowship training at Duke University. Dr. Demopulos received his M.D. from the Stanford University School of Medicine and his B.S. from Stanford University.

John A. Sedor

Pernix Therapeutics Holdings

An intuitive leader who engenders a deep level of trust and loyalty while providing a clear vision and business strategy, with a proven track record in the pharmaceutical, generic, biotechnology and consumer product industries. Recognized for entrepreneurial leadership approach to turnaround and rapid growth environments, leveraging strategic creativity, consumer and professional customer insight, merger and acquisition experience and operational expertise, all driving shareholder value. Open to contract C-level and Board of Director positions.

Dr. Albert Bourla

Pfizer

Albert Bourla (Greek: Άλμπερτ Μπουρλά, born) is a Greek veterinarian and the chairman and chief executive officer of Pfizer, an American pharmaceutical company. He joined the company in 1993 and has held several executive roles across Pfizer's divisions. Prior to becoming chief executive officer, Bourla served as chief operating officer.

Seth Lederman

Tonix Pharmaceuticals

Seth Lederman is a Co-Founder at Vela Pharmaceuticals Inc, Managing Member at Targent Inc, and Associate Professor at Columbia University. He has worked as Chairman at Lederle Laboratories, Associate Professor at Columbia University Vagelos College of Physicians and Surgeons, and Chairman/Founder at Tonix Pharmaceuticals. Seth attended Princeton University and Columbia University.

Paul Campanelli

Endo Pharmaceuticals Inc

Timothy P. Walbert

Horizon Pharma USA, Inc.

Carolyn Logan

Salix Pharmaceuticals

Brenton L. Saunders

Allergan plc

James D. Weir

Primus Pharmaceuticals

J.D. Weir is a Chief Executive Officer at PRIMUS PHARMACEUTICALS INC and is based in United States.

Craig C. Chambliss

Neurelis

Specialties: Corporate development, commercial operations, business development, regulatory, product development, mergers & acquisitions, fundraising